116175 ⎘
Hydrolases acting on ester bonds (3.1); Carboxylic ester hydrolases (3.1.1) Phospholipase A2 (3.1.1.4)
Method for Producing Lysophospholipid-Containing Composition and Method for Producing Oil-In-Water Emulsion Composition Using Same
#2YEAST EXPRESSING A HETEROLOGOUS PHOSPHOLIPASE FOR ETHANOL PRODUCTION
#3PLANT MILK PRODUCTION METHOD
#4GENE THERAPIES FOR TREATMENT OF INFANTILE NEUROAXONAL DYSTROPHY
#5RISANKIZUMAB COMPOSITIONS
#6STABILIZED FORMULA OF CROTOXIN
#7VECTORS AND METHODS FOR THE TREATMENT OF NEURODEGENERATION, DELAYING COGNITIVE DECLINE, AND IMPROVING MEMORY
#8RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF
#9SINGLE DOMAIN ANTIBODIES AGAINST BEE VENOM EPITOPES
#10PROCESS FOR ENZYMATIC OIL DEGUMMING INVOLVING PHOSPHOLIPASE A2
#11COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT
#12STABILIZED FORMULA OF CROTOXIN
#13ANTI-PLA2G2D CONSTRUCTS AND USES THEREOF
#14Use of Phospholipase A2 from Elapidae snakes in the treatment of diabetic nephropathy
#15IMMOBILIZED ENZYME FIBER REACTOR AND OIL REFINING USING THE SAME
#16ENZYMATIC TREATMENT OF FEEDSTOCK FOR HVO PRODUCTION
#17YEAST EXPRESSING A HETEROLOGOUS PHOSPHOLIPASE FOR ETHANOL PRODUCTION
#18RECOMBINANT YEAST HOST CELL HAVING ENHANCED GROWTH RATE
#19COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH MULTIPLE ORGAN FAILURE
#20Use of elapidae postsynaptic neurotoxin in the treatment of over expression of inflammatory cytokines related diseases
#21Bioactive Peptides, Compositions, Production Process, and Use of Bioactive Peptides as Anti-Tumoral Agents
#22METHODS OF SEPARATING HOST CELL LIPASES FROM AN ANTI-LAG3 ANTIBODY PRODUCTION
#23METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST
#24THERAPEUTIC METHODS AND COMPOSITIONS
#25cPLA2e INDUCING AGENTS AND USES THEREOF
#26COMPOSITION FOR PREVENTING OR TREATING OBESITY, COMPRISING PHOSPHOLIPASE A2 AS ACTIVE INGREDIENT
#27RECOMBINANT COMPONENTS AND COMPOSITIONS FOR USE IN FOOD PRODUCTS
#28Yeast expressing a heterologous phospholipase for ethanol production
#29Recombinant components and compositions for use in food products
#30Enzymatic modification of wheat phospholipids in bakery applications
#31Recombinant yeast strain for producing nervonic acids and application thereof
#32FERMENTED MILK PRODUCT AND PREPARATION THEREOF USING PHOSPHOLIPASE
#33METHODS OF TREATING LIVER DISEASES
#34Method for using lipase enzymes for cleaning
#35Lipase enzymes
#36Measurement of Lp-PLAactivity
#37Lipase variants and polynucleotides encoding same
#38Parkinson's disease model and methods
#39Methods of reducing foam during ethanol fermentation
#40Method of inhibiting the enzymatic activity of vascular endothelial lipase with a monoclonal antibody
#41Bakery products
#42COMPOSITIONS FOR BAKED PRODUCTS CONTAINING LIPOLYTIC ENZYMES AND USES THEREOF
#43High-secretion heat-resistant yeast genetically engineered strain and application thereof
#44Baking lipase and methods of use
#45Lipase variants and polynucleotides encoding same
#46IMPROVED ENZYMATIC MODIFICATION OF WHEAT PHOSPHOLIPIDS IN BAKERY APPLICATIONS
#47Methods for improving expression levels of foreign proteins by means of phospholipase fusion expression
#48USE OF PHOSPHOLIPASE C
#49Method for producing lysophosphatidylethanolamine 18:1 from microorganism of sp
#50Concentrated Solution of 17-Hydroxydocosahexaenoic Acid
#51Reagent kit used for detecting lipoprotein-associated phospholipase A2, and preparation method and application for reagent kit
#52Parkinsons disease model and methods
#53Cake batters
#54Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
#55Compositions and methods for the treatment of systemic inflammatory response syndromes
#56AgsE-deficient strain
#57Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
#58Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
#59sPLA2 MONITORING STRIP
#60COMPOSITION FOR THE ENZYMATIC DEGUMMING OF OIL
#61FLAVOR-IMPROVING ENZYME COMPOSITION, METHOD FOR SUPPRESSING OCCURRENCE OF UNPLEASANT ODOR, AND METHOD FOR MANUFACTURING FOOD WITH REDUCED UNPLEASANT ODOR
#62VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE
#63Therapeutic methods and compositions
#64Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
#65Strain secreting fatty acids by phospholipase and method for producing fatty acids using it
#66Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides
#67Cloning, expression and use of acid phospholipases
#68Polypeptides Having Chlorophyllase Activity and Polynucleotides Encoding Same
#69AgsE-deficient strain
#70Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
#71venom administration for cancer treatment
#72VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE
#73Composition for enzymatic oil degumming
#74Disease control with tick phospholipase A2
#75Compositions and methods for the treatment of systemic inflammatory response syndromes
#76Preparation of dough or baked products
#77Crotoxin administration for cancer treatment and pain relief
#78PLA2ACTIVITY AS A MARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS
#79Generation of triacylglycerols
#80Enzymatic Pretreatment For Making Dried Fruits
#81SERINE HYDROLASE FORMULATION
#82Antisense oligonucleotides against cPLA, compositions and uses thereof
#83Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
#84Cloning, expression and use of acid phospholipases
#85Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
#86Variant lipolytic enzymes and methods for expression thereof
#87Preparation of Dough or Baked Products
#88Compositions and methods for the treatment of sepsis and other disorders involving phospholipase Ainduction
#89Fertilization modulation compounds and process for implementing them
#90Enzymatic generation of functional lipids from cereals or cereal bi-streams
#91Disease control with tick phospholipase A
#92Method of inhibiting prostate cancer cell proliferation
#93phytase
#94Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
#95Crotoxin Administration for Cancer Treatment and Pain Relief
#96PREPARATION OF DOUGH OR BAKED PRODUCT
#97Method of using lipid acyltransferase
#98Methods of treatment of skin ulcers
#99THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS
#100Method to produce cake
#101Method of preparing a cake using phospholipase
#102Koji mold-origin phospholipase A
#103Phospholipase(s) and use(s) thereof
#104Generation of triacylglycerols from gums
#105Emulsification-free degumming of oil
#106Antisense oligonucleotides against cPLA, compositions and uses thereof
#107Hafnia phytase
#108Process for Producing Cheese
#109Method of inhibiting prostate cancer cell proliferation
#110Method
#111THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS
#112Process for producing cheese
#113Process for Producing Cheese
#114Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action
#115Modulation of telomere length by oligonucleotides having a G-core sequence
#116PREPARATION OF DOUGH OR BAKED PRODUCTS
#117Use of a phospholipase A2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids
#118Phospholipase(s) and use(s) thereof
#119Method of using lipid acyltransferase
#120Method of using lipid acyltransferase
#121Antiviral oligonucleotides having a conserved G4 core sequence
#122Koji mold-origin phospholipase a2
#123Method of using lipid acyltransferase
#124Method
#125Method of use of crotoxin as an anti-retroviral agent
#126Method of production and use of crotoxin as an analgesic
#127Methods and compositions for using aleveolar macrophage phospholipase A2
#128Phospholipase Aand gene thereof
#129Method of improving dough and bread quality
#130Methods and compositions for using alveolar macrophage phospholipase A2
#131Inhibition of calcium-independent phospholipases A2beta or A2gamma inhibit hormone-induced differentiation of 3T3-L1 preadipocytes
#132Antisense modulation of phospholipase A2, group IIA (synovial) expression
#133Method of preparing a dough or baked product made from a dough, with addition of lipolytic enzymes
#134Process for producing cheese